Spero Therapeutics, Inc. Realized Investment Gains (Losses)
Spero Therapeutics, Inc. (SPRO) reported Realized Investment Gains (Losses) of $1.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RealizedInvestmentGainsLosses · last filed 2021-03-11
- Spero Therapeutics, Inc. realized investment gains (losses) for the quarter ending 2019-12-31 was $0.00.
- Spero Therapeutics, Inc. realized investment gains (losses) for the quarter ending 2019-09-30 was $0.00.
- Spero Therapeutics, Inc. realized investment gains (losses) for the quarter ending 2019-06-30 was $0.00.
- Spero Therapeutics, Inc. realized investment gains (losses) for the quarter ending 2019-03-31 was $1.00K.
- Spero Therapeutics, Inc. realized investment gains (losses) for fiscal 2019 was $1.00K.
| Period end | Realized Investment Gains (Losses) 3 month | Realized Investment Gains (Losses) 6 month | Realized Investment Gains (Losses) 9 month | Realized Investment Gains (Losses) 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-11 | $0.00 derived: sum of 3 quarters · filed 2021-03-11 | $1.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $1.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $1.00K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |